Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Announcement Number Submissions Date(s) Sort descending Expiration Date Activity Code(s) Title
RFA-OD-19-011 May 26, 2019 T32 Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
PA-16-287 May 26, 2019 333 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
PAR-16-078 January 8, 2019 R21 Education and Health: New Frontiers (R21)
PAR-16-079 January 8, 2019 R03 Education and Health: New Frontiers (R03)
PAR-16-080 January 8, 2019 R01 Education and Health: New Frontiers (R01)
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
RFA-MH-17-240 NNovember 23, 2016 and October 13, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. October 14, 2017 R01 BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01)
RFA-NS-18-042 November 27, 2018; February 11, 2019; July 11,2019; November 12 , 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 13, 2019 R21 Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
RFA-NS-18-041 November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. March 13, 2020 R61/R33 Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
PA-17-478 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.The first standard due date for this FOA is February 5, 2018 January 8, 2021 R01 Research on Transgender Health (R01)
PA-18-590 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 777 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
PA-16-285 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. May 26, 2019 777 Change of Grantee Organization (Type 7 Parent)
PA-18-589 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 666 Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
PA-16-286 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. May 26, 2019 666 Successor-in-Interest (Type 6 Parent)
PAR-15-287 April 11, 2016; April 11, 2017; April 11, 2018, by 5:00 PM local time of applicant organization. April 12, 2018 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
PAR-18-646 April 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. April 12, 2018 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional)
PAR-18-951 April 15, 2019, April 15, 2020, April 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 16, 2021 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
PA-18-676 April 16, 2018 by 5:00 PM local time of applicant organization. April 17, 2018 333 Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp - Clinical Trial Optional)
RFA-HD-19-004 April 16, 2018, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
April 17, 2018 R43/R44 Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)
PAR-17-163 April 21, 2017, March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 30, 2019 R01 Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)
top of pageBACK TO TOP